相关实验视频

Updated: Jun 22, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

2-deoxy-2-[F]FDG PET成像用于对霍奇金淋巴瘤和非霍奇金淋巴瘤的治疗评估

Nadia Withofs¹, Christophe Bonnet², Roland Hustinx¹

¹Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, CHU of Liege, Quartier Hopital, Avenue de l'hopital 1, Liege, Belgium; GIGA-Nuclear Medicine Lab, University of Liege, CHU - B34 Quartier Hôpital, Avenue de l'Hôpital 11, Liège, BELGIQUE.

|June 30, 2024

概括

2-deoxy-2-[18F]-D-葡萄糖正子发射断层扫描与计算机断层扫描 (PET/CT) 结合,改善了淋巴瘤患者的治疗结果. 本综述涵盖了[18F]FDG PET/CT用于评估侵袭性淋巴瘤治疗反应.

科学领域:

在瘤学瘤学.
核医学是一种核医学.
放射学放射学是一门学科.

背景情况:

2-deoxy-2-[18F]-D-葡萄糖正子发射断层扫描与计算机断层扫描 ([18F]FDG PET/CT) 结合,显著改善了淋巴瘤护理中的患者结果.
它在分期和响应评估中的应用在临床实践和研究环境中都得到了很好的应用.

研究的目的:

审查目前关于[18F]FDG PET/CT对评估侵袭性淋巴瘤治疗反应的有用性的数据.
突出[18F]FDG PET/CT在管理具有挑战性的病例中的作用,包括晚期或耐药/复发性疾病.

主要方法:

本综述综合了当代研究和临床数据.
专注于评估[18F]FDG PET/CT的研究,以评估侵袭性淋巴瘤的治疗.

主要成果:

[18F]FDG PET/CT是监测侵袭性淋巴瘤治疗有效性的宝贵工具.
它的使用有助于优化患者管理,并可能降低治疗毒性.

结论:

[18F]FDG PET/CT在当代攻击性淋巴瘤的治疗中起着至关重要的作用.
[18F]FDG PET/CT的持续研究和应用对于进一步改善患者的治疗结果和最大限度地减少与治疗相关的副作用至关重要.

关键词:

适应的适应的评估评估的方法 DLBCL DLBCL 是一个字母.霍奇金 (Hodgkin) 是一个著名的作家.淋巴瘤是一种淋巴瘤.在这里,PET是PET.治疗疗法治疗疗法

更多相关视频

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT

Published on: April 29, 2017

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...